Oncology Drug Shortages in America

Vogel, Wendy H; Ervin, Robert S

doi:10.6004/jadpro.2012.3.2.4

Search citation statements

Order By: Relevance

Paper Sections

Select...

Why Is This Happening?1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

2022

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This shortage of DTIC is not the first shortage of oncolytic drugs, and it certainly will not be the last, 10 so studies must be conducted by regulatory bodies, oncology societies (American Society of Hematology and ASCO), and advocacy groups (Lymphoma Research Foundation and Leukemia and Lymphoma Society) in the United States and around the world to look into underlying causes. There are many contributing factors that affect the supply of oncolytic drugs, chemotherapeutics, and biologics alike.…”

Section: Why Is This Happening?mentioning

confidence: 99%